DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5833c9/global_vaccine_mar) has announced the addition of the "Global Vaccine Market" report to their offering.
Over the last few years vaccine has been one of the important contributors of healthcare revenue across the globe. The vaccine industry is experiencing a new, more dynamic period. Since the year 2000, the global vaccine market has almost tripled and making the vaccine industry one of the fastest growing sectors of industry.
Chronic diseases and increasing demand for different seasonal flu vaccines are the two most important factors driving the Global Vaccine market growth. Population below five years and increasing incidences of epidemics has also contributed to the increase in of sales of vaccines globally. In addition to the above factors the vaccine market is also expected to be driven by launch of new vaccines and the disease control campaign conducted on large scale by the government of various countries.
The report discusses the opportunities available for the vaccine players in the market. Huge untapped unvaccinated population in both developing and developed countries is expected to provide a big opportunity for the vaccine market players. The use of innovative manufacturing technology, growing support from public-private partnerships, and new funding resources and mechanisms are helping the development of vaccine industry.
The report also discusses the challenges faced by vaccine market. Government regulations, increasing market competition and difficulty in clinical trials are few of the challenges plaguing the vaccine industry. In addition to this, the report also focuses on the company profiles of some of the major players including the likes of GSK, Merck etc.
Key Topics Covered:
1. Market Overview: Vaccine Market
1.1 Market Size
1.2 Market Segmentation
1.3 Global Vaccine Market by Category
2. Market Trends
2.1 Rate of Vaccination by Geography
2.2 Collaboration with Small Players
3. Market Drivers
3.1 Pediatric Vaccines and Influenza Vaccines
3.2 Below 5 Years age population
3.3 Epidemic Incidences
4. Market Opportunities
4.1 Huge Untapped Unvaccinated Market
4.2 Governments Initiatives to increase Coverage of Vaccines across the globe
5. Market Challenges
5.1 High Entry Barriers
5.2 Government Regulations
5.3 Increasing Competition
5.4 Difficult and Capital Intensive Clinical Trials
6. Competitive Landscape
6.1 Market Share of Players
6.2 Competitors Matrix
7. Company Profiles
7.1 GSK
7.2 Merck
7.3 Novartis
7.4 Wyeth
8. Vaccine Market Outlook
For more information visit http://www.researchandmarkets.com/research/5833c9/global_vaccine_mar